| pubmed-article:11230471 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C0023452 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C0003993 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C1442162 | lld:lifeskim |
| pubmed-article:11230471 | lifeskim:mentions | umls-concept:C1550718 | lld:lifeskim |
| pubmed-article:11230471 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11230471 | pubmed:dateCreated | 2001-3-14 | lld:pubmed |
| pubmed-article:11230471 | pubmed:abstractText | To assess in a randomized study the therapeutic effect of the addition of high-dose L-asparaginase (HD ASP) in the context of a Berlin-Frankfurt-Münster (BFM)-based chemotherapy regimen for intermediate risk (IR) childhood acute lymphoblastic leukemia (ALL). | lld:pubmed |
| pubmed-article:11230471 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11230471 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11230471 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11230471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11230471 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11230471 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11230471 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11230471 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:BassoGG | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:MaseraGG | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:CasaleFF | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:AricòMM | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:ConterVV | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:RondelliRR | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:RizzariCC | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:Lo NigroLL | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:SantoroNN | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:ValsecchiM... | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:TestiAA | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:BarisoneEE | lld:pubmed |
| pubmed-article:11230471 | pubmed:author | pubmed-author:Associazione... | lld:pubmed |
| pubmed-article:11230471 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11230471 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11230471 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:11230471 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11230471 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11230471 | pubmed:pagination | 1297-303 | lld:pubmed |
| pubmed-article:11230471 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:meshHeading | pubmed-meshheading:11230471... | lld:pubmed |
| pubmed-article:11230471 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11230471 | pubmed:articleTitle | Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica. | lld:pubmed |
| pubmed-article:11230471 | pubmed:affiliation | Clinica Pediatrica dell'Università di Milano, Ospedale S. Gerardo, Monza, Italy. | lld:pubmed |
| pubmed-article:11230471 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11230471 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11230471 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11230471 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11230471 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11230471 | lld:pubmed |
